Cancer Patients Are Finding Anxiety Relief In Psychedelic Mushrooms

Dinah Bazer, a 69-year-old mother and retired information systems worker living in Brooklyn, credits psychedelics with saving her life. After undergoing chemotherapy for late-stage ovarian cancer in 2010, Bazer was consumed with anxiety and constant feelings of dread and hopelessness. So when her nurse told her about a clinical trial testing a new drug for cancer-related anxiety and depression ― high-dose psilocybin, the active ingredient in hallucinogenic mushrooms ― she signed up without hesitating.  Not long after ingesting the psilocybin during her session, Bazer found herself engulfed in utter terror. She visualized her fear as a black mass under her rib cage and yelled for it to “get the f. out!” Almost immediately, the fear left her completely. She shifted into a spiritual experience she described as bathing in God’s unconditional love for several hours.  Four years later, the experience is still with her and the fear is still gone. Bazer says she became calmer, let go of her aggressive driving habits and her phobia of flying, and reconnected with friends and loved ones. Most importantly, she was able to let go of her fear of death and truly embrace life. Her cancer is now in remission. “I want to enjoy life,” she told The Huffington Post. “I’m enjoying my life now, and I wasn’t before.”   A New Paradigm For Treating Cancer Anxiety  The results of the NYU-Langone Medical C...
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news